Eugene Litvak is President and CEO of the Institute for Healthcare Optimization. He is also an Adjunct Professor in Operations Management in the Department of Health Policy & Management at the Harvard School of Public Health (HSPH), where he teaches the course “Operations Management in Service Delivery Organizations”. Prior to his current position, he was a co-founder (with Michael C. Long, MD) and director of the Program for the Management of Variability in Health Care Delivery at the Boston University (BU) Health Policy Institute and a Professor at the BU School of Management. Before joining Boston University Dr. Litvak was a faculty member at the Harvard Center for Risk Analysis.
He was the co-author of the innovative cost-effective protocols in screening for HIV and hepatitis, which reduce the cost of screening by a factor of 5 to 10 while simultaneously reducing errors by a factor of 20 to 40. These protocols have been positively evaluated by the FDA, NIH, and CDC, which were the subject of a large-scale international trial supported by the U.S. Agency for International Development as well as Chiron and Roche pharmaceutical companies. Dr. Litvak served as a Principal Investigator from the U.S. for this trial.